Clinical Trials Directory

Trials / Unknown

UnknownNCT01686893

Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD

STIT-1 Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients With COPD

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Evaluation of Safety and Efficacy of Shorttime TNI Treatment in Patients with COPD Acute testing of oxygen demand using TNI vs. standard oxygen application in stable COPD patients An investigator-initiated, prospective, controlled, multicenter study

Detailed description

TNI, the nasal insufflation of a high flow of warm, humidified air, is an extremely comfortable and uncomplicated alternative to numerous other approaches in non-invasive ventilation (NIV). Up to now, NIV therapy could only be applied by masks with the associated complications as patients could not tolerate high airflow delivered by a thin nasal cannula without humidification and warming, thus causing concomitant negative effects. The new therapy TNI shows a high rate of acceptance by children, too. At present, there are two different types of devices available for nasal insufflation in clinics: TNI 20s, an air humidifier for clinical compressed air, and the TNI20 oxy, an air humidifier for clinical compressed air, which can be combined with oxygen. TNI 20 oxy The system, which is unique throughout the world, is optimized for the application of flows of up to 20L/min and fulfils the minimum requirements of the "American Society of Testing and Materials" for a high flow air humidifier in the non-invasive application of 10 mg H2O/L (equivalent to about 60% rel. humidity at an ambient temperature of 22°C) for the air humidity. The warming of the air flow by 5-15°C can be adjusted relative to the ambient temperature. Condensation is prevented in the nasal applicator by heating the tube as far as the nostrils. The device automatically controls humidity and temperature depending on the prevailing ambient conditions. The TNI®20s can be attached to the hospital infrastructure by means of a standard pressure regulator.

Conditions

Interventions

TypeNameDescription
DEVICENasal oxygen insufflation with a TNI 20 oxy deviceNasal oxygen insufflation with a TNI 20 oxy device
DEVICEStandard Nasal Insufflation of oxygenStandard Nasal Insufflation of oxygen

Timeline

Start date
2009-02-01
Primary completion
2013-02-01
Completion
2013-03-01
First posted
2012-09-18
Last updated
2012-09-19

Locations

3 sites across 3 countries: Austria, Germany, Switzerland

Source: ClinicalTrials.gov record NCT01686893. Inclusion in this directory is not an endorsement.